Literature DB >> 28574405

Multi-institutional MicroCT image comparison of image-guided small animal irradiators.

Chris D Johnstone1, Patricia Lindsay, Edward E Graves, Eugene Wong, Jessica R Perez, Yannick Poirier, Youssef Ben-Bouchta, Thilakshan Kanesalingam, Haijian Chen, Ashley E Rubinstein, Ke Sheng, Magdalena Bazalova-Carter.   

Abstract

To recommend imaging protocols and establish tolerance levels for microCT image quality assurance (QA) performed on conformal image-guided small animal irradiators. A fully automated QA software SAPA (small animal phantom analyzer) for image analysis of the commercial Shelley micro-CT MCTP 610 phantom was developed, in which quantitative analyses of CT number linearity, signal-to-noise ratio (SNR), uniformity and noise, geometric accuracy, spatial resolution by means of modulation transfer function (MTF), and CT contrast were performed. Phantom microCT scans from eleven institutions acquired with four image-guided small animal irradiator units (including the commercial PXi X-RAD SmART and Xstrahl SARRP systems) with varying parameters used for routine small animal imaging were analyzed. Multi-institutional data sets were compared using SAPA, based on which tolerance levels for each QA test were established and imaging protocols for QA were recommended. By analyzing microCT data from 11 institutions, we established image QA tolerance levels for all image quality tests. CT number linearity set to R 2  >  0.990 was acceptable in microCT data acquired at all but three institutions. Acceptable SNR  >  36 and noise levels  <55 HU were obtained at five of the eleven institutions, where failing scans were acquired with current-exposure time of less than 120 mAs. Acceptable spatial resolution (>1.5 lp mm-1 for MTF  =  0.2) was obtained at all but four institutions due to their large image voxel size used (>0.275 mm). Ten of the eleven institutions passed the set QA tolerance for geometric accuracy (<1.5%) and nine of the eleven institutions passed the QA tolerance for contrast (>2000 HU for 30 mgI ml-1). We recommend performing imaging QA with 70 kVp, 1.5 mA, 120 s imaging time, 0.20 mm voxel size, and a frame rate of 5 fps for the PXi X-RAD SmART. For the Xstrahl SARRP, we recommend using 60 kVp, 1.0 mA, 240 s imaging time, 0.20 mm voxel size, and 6 fps. These imaging protocols should result in high quality images that pass the set tolerance levels on all systems. Average SAPA computation time for complete QA analysis for a 0.20 mm voxel, 400 slice Shelley phantom microCT data set was less than 20 s. We present image quality assurance recommendations for image-guided small animal radiotherapy systems that can aid researchers in maintaining high image quality, allowing for spatially precise conformal dose delivery to small animals.

Entities:  

Mesh:

Year:  2017        PMID: 28574405      PMCID: PMC5800981          DOI: 10.1088/1361-6560/aa76b4

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  26 in total

1.  Quality assurance for image-guided radiation therapy utilizing CT-based technologies: a report of the AAPM TG-179.

Authors:  Jean-Pierre Bissonnette; Peter A Balter; Lei Dong; Katja M Langen; D Michael Lovelock; Moyed Miften; Douglas J Moseley; Jean Pouliot; Jan-Jakob Sonke; Sua Yoo
Journal:  Med Phys       Date:  2012-04       Impact factor: 4.071

2.  Implementation and commissioning of an integrated micro-CT∕RT system with computerized independent jaw collimation.

Authors:  Michael D Jensen; W Thomas Hrinivich; Jongho A Jung; David W Holdsworth; Maria Drangova; Jeff Chen; Eugene Wong
Journal:  Med Phys       Date:  2013-08       Impact factor: 4.071

3.  Functional interrogation of adult hypothalamic neurogenesis with focal radiological inhibition.

Authors:  Daniel A Lee; Juan Salvatierra; Esteban Velarde; John Wong; Eric C Ford; Seth Blackshaw
Journal:  J Vis Exp       Date:  2013-11-14       Impact factor: 1.355

4.  The importance of tissue segmentation for dose calculations for kilovoltage radiation therapy.

Authors:  Magdalena Bazalova; Edward E Graves
Journal:  Med Phys       Date:  2011-06       Impact factor: 4.071

5.  Characterization of image quality and image-guidance performance of a preclinical microirradiator.

Authors:  R Clarkson; P E Lindsay; S Ansell; G Wilson; S Jelveh; R P Hill; D A Jaffray
Journal:  Med Phys       Date:  2011-02       Impact factor: 4.071

6.  Development of a micro-computed tomography-based image-guided conformal radiotherapy system for small animals.

Authors:  Hu Zhou; Manuel Rodriguez; Fred van den Haak; Geoffrey Nelson; Rahil Jogani; Jiali Xu; Xinzhi Zhu; Yongjiang Xian; Phuoc T Tran; Dean W Felsher; Paul J Keall; Edward E Graves
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-13       Impact factor: 7.038

7.  Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas.

Authors:  Jing Zeng; Alfred P See; Jillian Phallen; Christopher M Jackson; Zineb Belcaid; Jacob Ruzevick; Nicholas Durham; Christian Meyer; Timothy J Harris; Emilia Albesiano; Gustavo Pradilla; Eric Ford; John Wong; Hans-Joerg Hammers; Dimitris Mathios; Betty Tyler; Henry Brem; Phuoc T Tran; Drew Pardoll; Charles G Drake; Michael Lim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-02-22       Impact factor: 7.038

8.  High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities.

Authors:  John Wong; Elwood Armour; Peter Kazanzides; Iulian Iordachita; Erik Tryggestad; Hua Deng; Mohammad Matinfar; Christopher Kennedy; Zejian Liu; Timothy Chan; Owen Gray; Frank Verhaegen; Todd McNutt; Eric Ford; Theodore L DeWeese
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-01       Impact factor: 7.038

9.  Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models.

Authors:  Grit S Herter-Sprie; Houari Korideck; Camilla L Christensen; Jan M Herter; Kevin Rhee; Ross I Berbeco; David G Bennett; Esra A Akbay; David Kozono; Raymond H Mak; G Mike Makrigiorgos; Alec C Kimmelman; Kwok-Kin Wong
Journal:  Nat Commun       Date:  2014-12-18       Impact factor: 14.919

10.  PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma.

Authors:  Kelly L Barton; Katherine Misuraca; Francisco Cordero; Elena Dobrikova; Hooney D Min; Matthias Gromeier; David G Kirsch; Oren J Becher
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more
  4 in total

1.  The effect of different image reconstruction techniques on pre-clinical quantitative imaging and dual-energy CT.

Authors:  Ana Vaniqui; Lotte E J R Schyns; Isabel P Almeida; Brent van der Heyden; Mark Podesta; Frank Verhaegen
Journal:  Br J Radiol       Date:  2018-11-07       Impact factor: 3.039

2.  Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma.

Authors:  Jun W Kim; Cesar P Marquez; Kaja Kostyrko; Amanda L Koehne; Kieren Marini; David R Simpson; Alex G Lee; Stanley G Leung; Leanne C Sayles; Joseph Shrager; Irene Ferrer; Luis Paz-Ares; Melanie Hayden Gephart; Silvestre Vicent; Jennifer R Cochran; E Alejandro Sweet-Cordero
Journal:  Nat Med       Date:  2019-11-07       Impact factor: 53.440

3.  Virtual monoenergetic micro-CT imaging in mice with artificial intelligence.

Authors:  Brent van der Heyden; Stijn Roden; Rüveyda Dok; Sandra Nuyts; Edmond Sterpin
Journal:  Sci Rep       Date:  2022-02-11       Impact factor: 4.379

4.  Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues.

Authors:  Bhavesh D Kevadiya; Brendan Ottemann; Insiya Z Mukadam; Laura Castellanos; Kristen Sikora; James R Hilaire; Jatin Machhi; Jonathan Herskovitz; Dhruvkumar Soni; Mahmudul Hasan; Wenting Zhang; Sarella Anandakumar; Jered Garrison; JoEllyn McMillan; Benson Edagwa; R Lee Mosley; Richard W Vachet; Howard E Gendelman
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.